Identification of Potential Therapeutic Targets Against Anthrax-Toxin-Induced Liver and Heart Damage

Area of Science:

• Toxicology
• Molecular Biology
• Genetics

Background:

• Anthrax is a severe disease caused by Bacillus anthracis toxins.
• Understanding toxin mechanisms is crucial for developing effective treatments.
• Identifying host-pathogen interactions can reveal therapeutic targets.

Purpose of the Study:

• To identify novel therapeutic targets against anthrax toxins.
• To investigate the molecular mechanisms of anthrax toxin-induced damage in liver and heart cells.
• To validate potential therapeutic targets through gene knockdown and knockout studies.

Main Methods:

• Cell viability, apoptosis, and metabolic assays were performed on hepatocytes and cardiomyocytes.
• Microarray analysis was used to identify genes involved in toxin-induced toxicity.
• Gene knockdown and knockout mouse models were employed for target validation.

Main Results:

• Anthrax edema toxin (EdTx) and lethal toxin (LeTx) caused significant damage to mouse liver and heart, respectively.
• Specific gene knockdowns (Rgs1, Hcar2, Fosl2, Cxcl2, Cxcl3) protected hepatocytes from EdTx.
• Serpine1 (encoding PAI-1) was upregulated by LeTx, and PAI-1 knockout mice showed increased LeTx tolerance.

Conclusions:

• Rgs1, Hcar2, Fosl2, Cxcl2, and Cxcl3 are potential targets for mitigating EdTx-induced liver damage.
• PAI-1 is essential for LeTx-induced toxicity and represents a promising therapeutic target for LeTx-mediated tissue damage.
• This research provides valuable insights into anthrax toxin pathology and identifies key targets for future therapeutic interventions.